首頁 > 市場調查報告書 > 醫療設備

心血管設備循環系統

市場調查報告書

商品編碼

1671852

心房顫動市場按類型、治療方法、技術、最終用戶和地區分類

Atrial Fibrillation Market, By Type, By Treatment, By Technology, By End User, By Geography

出版日期: 2025年02月26日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球心房顫動市場規模估計為 264.3 億美元，預計到 2032 年將達到 435.7 億美元，2025 年至 2032 年的複合年成長率為 7.4%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	264.3億美元
效能資料	從 2020 年到 2024 年	預測期	2025 至 2032 年
預測期：2025-2032年複合年成長率：	7.40％	2032 年價值預測	435.7億美元

數字。 2025 年心房顫動市場佔有率（按地區分類）

心房顫動是世界上最常見的心律不整，確診病例的盛行率正在迅速增加。老年人口的增加、心血管疾病和文明病的盛行率不斷上升、侵入性心血管手術的增加以及診斷和治療設備的技術進步是推動該市場成長的一些主要因素。然而，與心房顫動診斷和治療相關的血栓性栓塞症風險以及開發中國家對心房顫動缺乏認知預計會阻礙市場的成長。

市場動態：

推動全球心房顫動市場成長的關鍵因素是易患心房顫動的老年人口的快速增加、肥胖和高血壓盛行率的上升、酒精和菸草消費量的增加以及侵入性心血管手術的增加。然而，與心房顫動的診斷和治療相關的血栓性栓塞症風險高以及新興國家對心房顫動缺乏認知預計會阻礙市場的成長。新型消融技術的研發以及提供創新解決方案的新興企業的出現將在未來幾年提供重大機會。

本研究的主要特點

本報告對全球心房顫動市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。

它還強調了各個領域的潛在商機並說明了該市場的引人注目的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球心房顫動市場的主要企業是根據公司亮點、產品系列、關鍵亮點、財務績效和策略等參數進行的分析。

這項研究涉及的主要企業包括輝瑞公司、勃林格殷格翰公司、百時美施貴寶公司、強生公司、雅培實驗室、波士頓科學公司、美敦力公司、AtriCure 公司、賽諾菲公司、拜耳公司、吉利德科學公司、安進公司和默克公司。

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球心房顫動市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過分析全球心房顫動市場所使用的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	US$ 26.43 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.40%	2032 Value Projection:	US$ 43.57 Bn

Atrial fibrillation is the most common cardiac arrhythmia globally and the prevalence of diagnosed cases is growing rapidly. Rising geriatric population, increasing incidence of cardiovascular & lifestyle diseases, growth in invasive cardiac procedures, and technological advancements in diagnostic and treatment devices are some of the key factors fueling the growth of this market. However, risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are expected to hamper market growth.

Market Dynamics:

The key drivers propelling the growth of global atrial fibrillation market are rapid growth in geriatric population who are more susceptible to atrial fibrillation, rising prevalence of obesity and hypertension, increasing consumption of alcohol and tobacco, and growing number of invasive cardiac surgeries. However, high risk of thromboembolism associated with atrial fibrillation diagnosis and treatment and lack of awareness about atrial fibrillation in developing countries are projected to hinder the market growth. Growing research on development of novel ablation technologies and emergence of start-up companies offering innovative solutions present significant opportunities in the coming years.

Key Features of the Study:

This report provides in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global atrial fibrillation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, AtriCure, Inc., Sanofi, Bayer AG, Gilead Sciences, Inc., Amgen Inc., Merck & Co., Inc., St. Jude Medical, Inc., and Cardiovascular Systems, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market

Market Segmentation

Type Insights (Revenue, USD Bn, 2020 - 2032)
- Paroxysmal Atrial Fibrillation
- Persistent Atrial Fibrillation
- Permanent Atrial Fibrillation
Treatment Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmacological Treatments
- Anticoagulants
- Antiarrhythmic Drugs
- Non-Pharmacological Treatments
- Catheter Ablation
- Surgical Procedures
- Implantable Devices
Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Radiofrequency
- Laser
- Cryotherapy
- Others
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Cardiac Centers
- Home Care Settings
- Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Johnson & Johnson
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- AtriCure, Inc.
- Sanofi
- Bayer AG
- Gilead Sciences, Inc.
- Amgen Inc.
- Merck & Co., Inc.
- Jude Medical, Inc.
- Cardiovascular Systems, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Atrial Fibrillation Market, By Type
- Global Atrial Fibrillation Market, By Treatment
- Global Atrial Fibrillation Market, By Technology
- Global Atrial Fibrillation Market, By End User
- Global Atrial Fibrillation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Atrial Fibrillation Market, By Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Paroxysmal Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Persistent Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Permanent Atrial Fibrillation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Atrial Fibrillation Market, By Treatment, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmacological Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anticoagulants
- Antiarrhythmic Drugs
Non-Pharmacological Treatments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Catheter Ablation
- Surgical Procedures
- Implantable Devices

6. Global Atrial Fibrillation Market, By Technology, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Radiofrequency
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Laser
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cryotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Atrial Fibrillation Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiac Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Atrial Fibrillation Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AtriCure, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
Bayer AG
Gilead Sciences, Inc.
Amgen Inc.
Merck & Co., Inc.
Jude Medical, Inc.
Cardiovascular Systems, Inc.